FBRX
Forte Biosciences IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$359.61M
P/E Ratio
—
EPS
$-4.58
Beta
2.87
52W High
$35.80
52W Low
$9.10
50-Day MA
$24.75
200-Day MA
$22.20
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Forte Biosciences Inc
Forte Biosciences Inc. is a clinical-stage biopharmaceutical company in the United States. The company is headquartered in Torrance, California.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | $-76.90M |
| Operating Margin | 0.00% |
| Return on Equity | -188.40% |
| Return on Assets | -83.90% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $2.36 |
| Price-to-Book | 8.44 |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | 1.87 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $20.48M |
| Float | $18.83M |
| % Insiders | 2.15% |
| % Institutions | 74.81% |
Historical Volatility
HV 10-Day
71.63%
HV 20-Day
75.39%
HV 30-Day
76.49%
HV 60-Day
94.24%
HV Rank
22.6%
Volatility is currently contracting
Analyst Ratings
Consensus ($63.75 target)
5
BuyMore HEALTHCARE Stocks
Data last updated: 6/13/2026